UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

The majority of microRNAs detectable in serum and saliva is concentrated in exosomes

PloS one, 2012-03, Vol.7 (3), p.e30679-e30679

2012

Volltextzugriff (PDF)

Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis

Immunity (Cambridge, Mass.), 2012-12, Vol.37 (6), p.1104-1115

2012

Volltextzugriff (PDF)

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2017-02, Vol.69 (2), p.376-386

2017

Volltextzugriff (PDF)

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

Annals of the rheumatic diseases, 2016-11, Vol.75 (11), p.1909-1916

2016

Volltextzugriff (PDF)

MicroRNAs as biomarkers in rheumatic diseases

Nature reviews. Rheumatology, 2010-07, Vol.6 (7), p.391

2010

Volltextzugriff (PDF)

Basophils and the T helper 2 environment can promote the development of lupus nephritis

Nature medicine, 2010-06, Vol.16 (6), p.701-707

2010

Volltextzugriff (PDF)

Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.706

2018

Volltextzugriff (PDF)

Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

Journal of the American Society of Nephrology, 2009-04, Vol.20 (4), p.901-911

2009

Volltextzugriff (PDF)

MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2011-02, Vol.63 (2), p.535-544

2011

Volltextzugriff (PDF)

miR-150 Promotes Renal Fibrosis in Lupus Nephritis by Downregulating SOCS1

Journal of the American Society of Nephrology, 2013-07, Vol.24 (7), p.1073-1087

2013

Volltextzugriff (PDF)

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2013-01, Vol.72 (1), p.118-128

2013

Volltextzugriff (PDF)

Cytokines in Sjögren's syndrome: potential therapeutic targets

Annals of the Rheumatic Diseases, 2010-06, Vol.69 (6), p.945-948

2010

Volltextzugriff (PDF)

LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration

Arthritis research & therapy, 2019-12, Vol.21 (1), p.276-276, Article 276

2019

Volltextzugriff (PDF)

MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease

Autoimmunity reviews, 2010-07, Vol.9 (9), p.618-621

2010

Volltextzugriff (PDF)

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

Nature genetics, 2013-11, Vol.45 (11), p.1284-1292

2013

Volltextzugriff (PDF)

Identification and characterization of circulating human transitional B cells

Blood, 2005-06, Vol.105 (11), p.4390-4398

2005

Volltextzugriff (PDF)

Pathogenesis of Sjögrenʼs syndrome

Current opinion in rheumatology, 2009-09, Vol.21 (5), p.465-470

2009

Volltextzugriff (PDF)

Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures

Blood, 2009-05, Vol.113 (21), p.5125-5133

2009

Volltextzugriff (PDF)

miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1

Journal of the American Society of Nephrology, 2013-07, Vol.24 (7), p.1073-1087

2013

Volltextzugriff (PDF)

Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.459-471

2021

Volltextzugriff (PDF)

Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (47), p.19403-19407

2012

Volltextzugriff (PDF)

Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus

Science translational medicine, 2021-05, Vol.13 (595)

2021

Volltextzugriff (PDF)

Urinary exosomal transcription factors, a new class of biomarkers for renal disease

Kidney international, 2008-09, Vol.74 (5), p.613-621

2008

Volltextzugriff (PDF)

Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus

Rheumatology (Oxford, England), 2022-08, Vol.61 (8), p.3317-3328

2022

Volltextzugriff (PDF)

circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus Nephritis

Oxidative medicine and cellular longevity, 2022-10, Vol.2022, p.1-17

2022

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Humans
(91)
Life Sciences & Biomedicine
(91)
Rheumatology
(48)
Female
(42)
Male
(38)
Adult
(36)
Biological And Medical Sciences
(33)
Medical Sciences
(31)
Middle Aged
(28)
Lupus
(22)
Lupus Erythematosus, Systemic - Immunology
(16)
Animals
(15)
Biomarkers
(15)
Diseases Of The Osteoarticular System
(15)
Systemic Lupus Erythematosus
(14)
Aged
(13)
Immunology
(13)
Autoimmune Diseases
(11)
Gene Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The majority of microRNAs detectable in serum and saliva is concentrated in exosomes

Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

MicroRNAs as biomarkers in rheumatic diseases

Basophils and the T helper 2 environment can promote the development of lupus nephritis

Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome

miR-150 Promotes Renal Fibrosis in Lupus Nephritis by Downregulating SOCS1

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus

Cytokines in Sjögren's syndrome: potential therapeutic targets

LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration

MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

Identification and characterization of circulating human transitional B cells

Pathogenesis of Sjögrenʼs syndrome

Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures

miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1

Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus

Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction

Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus

Urinary exosomal transcription factors, a new class of biomarkers for renal disease

Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus

circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus Nephritis

Suchergebnisse filtern